Ownership

David Watson - General Counsel at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: General Counsel
Stock Symbol: APLS on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

David Watson - trading volume in the past year for Apellis Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-14K	100%	$63.48	-$890K
Net	-14K	-100%		-$890K

Holdings reported by David Watson for Apellis Pharmaceuticals, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	118K	$1.55M	$13.19	Sep 27, 2024	Direct
Common Stock	70.1K	$925K	$13.19	Sep 27, 2024	Indirect Owner (The David O. Watson Irrevocable Trust of 2023)
Common Stock	6.67K	$87.9K	$13.19	Sep 27, 2024	Indirect Owner (The Watson Education Trust)
Common Stock	3.33K	$44K	$13.19	Sep 27, 2024	Indirect Owner (Custodial Account for Son)
Stock Option (Right to Buy)	0	$0	$66.30	Mar 6, 2024	Direct	Common Stock

Transactions reported by David Watson for Apellis Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.